Literature DB >> 11095814

Managing Resistant Trichomonas Vaginitis.

.   

Abstract

Vaginal trichomoniasis is a sexually transmitted disease of worldwide importance that is commonly treated with metronidazole. Although surprisingly uncommon, resistance to metronidazole has nevertheless been widely reported. Patients with suspected resistant trichomoniasis should have the diagnosis confirmed either by visualization of motile trichomonads on saline microscopy or by culture. In addition, reinfection from a partner must be ruled out through a careful history. Data regarding treatment of metronidazole-resistant trichomoniasis are mainly limited to case reports or series. Most cases can be treated successfully with increasing doses of oral metronidazole. Other promising options include oral tinidazole and topical paromomycin cream.

Entities:  

Year:  1999        PMID: 11095814     DOI: 10.1007/s11908-999-0047-x

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  25 in total

1.  Successful response of metronidazole-resistant trichomonal vaginitis to tinidazole. A case report.

Authors:  K A Hamed; A E Studemeister
Journal:  Sex Transm Dis       Date:  1992 Nov-Dec       Impact factor: 2.830

2.  Difficult-to-treat trichomoniasis: results with paromomycin cream.

Authors:  P Nyirjesy; J D Sobel; M V Weitz; D J Leaman; S P Gelone
Journal:  Clin Infect Dis       Date:  1998-04       Impact factor: 9.079

3.  Clinical and microbiological correlates of vaginal trichomoniasis during pregnancy. The Vaginal Infections and Prematurity Study Group.

Authors:  J G Pastorek; M F Cotch; D H Martin; D A Eschenbach
Journal:  Clin Infect Dis       Date:  1996-11       Impact factor: 9.079

4.  Paromomycin for nitroimidazole-resistant trichomonosis.

Authors:  P Nyirjesy; M V Weitz; S P Gelone; T Fekete
Journal:  Lancet       Date:  1995-10-21       Impact factor: 79.321

5.  Metronidazole resistant Trichomonas vaginalis in Brisbane.

Authors:  T Voolmann; P Boreham
Journal:  Med J Aust       Date:  1993-10-04       Impact factor: 7.738

6.  Safety of metronidazole in pregnancy: a meta-analysis.

Authors:  P Burtin; A Taddio; O Ariburnu; T R Einarson; G Koren
Journal:  Am J Obstet Gynecol       Date:  1995-02       Impact factor: 8.661

7.  Demographic and behavioral predictors of Trichomonas vaginalis infection among pregnant women. The Vaginal Infections and Prematurity Study Group.

Authors:  M F Cotch; J G Pastorek; R P Nugent; D E Yerg; D H Martin; D A Eschenbach
Journal:  Obstet Gynecol       Date:  1991-12       Impact factor: 7.661

8.  In vitro susceptibility of Trichomonas vaginalis to metronidazole and treatment outcome in vaginal trichomoniasis.

Authors:  M Müller; J G Lossick; T E Gorrell
Journal:  Sex Transm Dis       Date:  1988 Jan-Mar       Impact factor: 2.830

9.  An incremental dosing protocol for women with severe vaginal trichomoniasis and adverse reaction to metronidazole.

Authors:  M D Pearlman; C Yashar; S Ernst; W Solomon
Journal:  Am J Obstet Gynecol       Date:  1996-03       Impact factor: 8.661

Review 10.  Trichomoniasis in men: old issues and new data.

Authors:  J N Krieger
Journal:  Sex Transm Dis       Date:  1995 Mar-Apr       Impact factor: 2.830

View more
  1 in total

1.  Antimicrobial Resistance in Vulvovaginitis.

Authors:  Jack D. Sobel
Journal:  Curr Infect Dis Rep       Date:  2001-12       Impact factor: 3.725

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.